ITERUM THERAPEUTICS PLC (ITRMF)
Institutional ownership reported to the SEC as of Q2 2026, across 16 quarters.
2
Reporting holders
$542
Reported value
0.0%
Held as options
-14
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| BARCLAYS PLC | $539 | 10,795 | 0.00% | new | NEW |
| Cypress Capital Management LLC (WY) | $3 | 66 | 0.00% | 2q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2 | $542 | 10,861 | 1 | 0 | 0 | 0.0% |
| Q1 2026 | 16 | $14.3K | 489,601 | 9 | 3 | 1 | 0.0% |
| Q4 2025 | 14 | $472.0K | 1,409,034 | 2 | 3 | 2 | 0.0% |
| Q3 2025 | 17 | $755.9K | 1,114,659 | 3 | 2 | 5 | 0.0% |
| Q2 2025 | 20 | $2.3M | 2,300,967 | 4 | 4 | 1 | 0.0% |
| Q1 2025 | 18 | $1.3M | 1,048,600 | 2 | 2 | 3 | 0.0% |
| Q4 2024 | 20 | $2.1M | 1,187,113 | 9 | 3 | 1 | 0.0% |
| Q3 2024 | 15 | $2.2M | 2,040,705 | 6 | 1 | 1 | 0.0% |
| Q2 2024 | 14 | $494.7K | 431,516 | 3 | 0 | 4 | 0.0% |
| Q1 2024 | 14 | $1.3M | 829,236 | 4 | 3 | 0 | 0.0% |
| Q4 2023 | 13 | $674.2K | 342,059 | 2 | 0 | 3 | 0.0% |
| Q3 2023 | 12 | $145.9K | 179,825 | 1 | 3 | 1 | 0.0% |
| Q2 2023 | 13 | $347.3K | 324,599 | 2 | 1 | 1 | 0.0% |
| Q1 2023 | 13 | $138.2K | 138,174 | 3 | 1 | 2 | 0.0% |
| Q4 2022 | 12 | $139.4K | 165,932 | 5 | 2 | 1 | 0.0% |
| Q3 2022 | 13 | $333.4K | 206,491 | 13 | 0 | 0 | 0.0% |